GlassScriptPhysician profile
Jose A Carrillo
NPI 1902006661
$3,462.44
in general payments reported to CMS, 2019-2025
33 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $1,153 · 2021: $155 · 2022: $446 · 2023: $243 · 2024: $403 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141 · Education: $24.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.45 |
| Education | $24.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $921.93 | 2020 | |
| Novocure INC. | $710.51 | 2019-2023 | Optune |
| Ucb, INC. | $383.62 | 2019-2024 | Rystiggo, Briviact, Nayzilam |
| Springworks Therapeutics, INC. | $226.88 | 2025 | Gomekli |
| Merck Sharp & Dohme LLC | $221.88 | 2022-2024 | Welireg, Keytruda |
| Allergan, INC. | $128.41 | 2020 | |
| Jazz Pharmaceuticals INC. | $105.34 | 2025 | |
| Monteris Medical Corporation | $81.34 | 2019-2021 | |
| Integra Lifesciences Corporation | $62.17 | 2020 | |
| Seagen INC. | $53.32 | 2022 | |
| Caris Mpi, INC. | $48.13 | 2025 | Mi Cancer Seek |
| Depuy Synthes Sales INC. | $48.00 | 2019 | |
| Telix Pharmaceuticals | $42.25 | 2025 | Illuccix |
| Tersera Therapeutics LLC | $40.00 | 2024 | Xermelo |
| Pfizer INC. | $37.10 | 2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $34.10 | 2019 | |
| Catalyst Pharmaceuticals, INC. | $29.48 | 2021 | |
| Day One Biopharmaceuticals | $29.13 | 2025 | Ojemda |
| Servier Pharmaceuticals LLC | $25.68 | 2025 | |
| Novartis Pharmaceuticals Corporation | $24.27 | 2019 | |
| Sk Life Science, INC. | $23.75 | 2021 | |
| Alexion Pharmaceuticals, INC. | $23.66 | 2025 | Koselugo |
| Array Biopharma INC | $21.09 | 2024 | Mektovi, Lorbrena, Braftovi |
| Boston Scientific Corporation | $20.13 | 2019 | |
| Chiesi USA, INC. | $20.06 | 2020 | |
| Kyowa Kirin, INC. | $19.18 | 2019 | |
| Inspire Medical Systems, INC. | $18.76 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $17.42 | 2019 | |
| Gt Medical Technologies, INC | $16.68 | 2019 | |
| Ge Healthcare | $14.54 | 2022 | |
| Medtronic, INC. | $13.63 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Carrillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.